Precision Oncology Platform

TumorQ by NEXQ

TumorQ is a healthcare delivery platform built around quantum machine learning, tumor mapping, secure treatment planning, and proprietary multi-layer quantum encryption for modern oncology workflows.

TUMORQ BASELINE ACCURACY

99.98%

PEEL FOR CONTEXT.

TUMORQ BASELINE ACCURACY

99.98%

Baseline oncology performance marker for secure segmentation and intervention framing.

Tumor mapping and delivery targeting

3D

PEEL FOR CONTEXT.

Tumor mapping and delivery targeting

3D

Three-dimensional route planning for region-aware tumor review and treatment discussion.

Compliance language preserved

HIPAA / GDPR

PEEL FOR CONTEXT.

Compliance language preserved

HIPAA / GDPR

Regulatory posture carried through identity, storage, and role-separated collaboration lanes.

Why organizations choose this program

Platform strengths for secure healthcare deployment.

These strengths show how NEXQ combines clinical relevance, secure operations, and deployment-ready product structure.

Strength 01

Healthcare-first approach

PEEL FOR CONTEXT.

Strength 01

Healthcare-first approach

Built for cancer diagnostics, treatment planning, and care delivery rather than generic analytics use cases.

Strength 02

Compliance-ready framing

PEEL FOR CONTEXT.

Strength 02

Compliance-ready framing

TumorQ is structured around HIPAA, GDPR, role-based permissions, encryption, and enterprise SSO requirements.

Strength 03

Future-proof technology

PEEL FOR CONTEXT.

Strength 03

Future-proof technology

Quantum encryption and AI-assisted clinical insight are presented as long-term architecture rather than one-off product features.

Strength 04

Proven-results positioning

PEEL FOR CONTEXT.

Strength 04

Proven-results positioning

TumorQ is designed for hospitals, research institutions, and biotech teams working to improve outcomes and reduce operational drag.

Technical abilities

A capability map for this product route.

Each product page surfaces technical depth, operational readiness, and product direction for clinical, research, and enterprise audiences.

3D targeting and region-aware analysis

Tumor segmentation pipeline

PEEL FOR CONTEXT.

3D targeting and region-aware analysis

Tumor segmentation pipeline

Structure imaging intake, sectionalization, and review outputs into a cleaner clinician-facing story.

HIPAA / GDPR framing

Secure collaboration controls

PEEL FOR CONTEXT.

HIPAA / GDPR framing

Secure collaboration controls

Bring encryption, role-based permissions, and compliant retention language into the product surface with proprietary hybrid and mini-hybrid-fault-tolerant quantum encryption modes.

Real-time adaptability narrative

Clinical decision support

PEEL FOR CONTEXT.

Real-time adaptability narrative

Clinical decision support

Position model output as a support layer for diagnosis and treatment planning, not as isolated model performance.

Starter to Enterprise path

Biotech and research readiness

PEEL FOR CONTEXT.

Starter to Enterprise path

Biotech and research readiness

Keep research institutions, biotech teams, and hospitals in the same operating model with deployment lanes that scale.

Deployment lanes

Who this route is designed to serve.

Each product page shows how clinical, research, and enterprise conversations differ across the program.

Fast interpretation and controlled access

Clinical teams

PEEL FOR CONTEXT.

Fast interpretation and controlled access

Clinical teams

Use TumorQ for secure diagnostic review, care planning, and coordinated case discussions.

Shared scientific context

Research institutions

PEEL FOR CONTEXT.

Shared scientific context

Research institutions

Support oncology studies with model-assisted analysis, reproducible workflows, and privacy-aware collaboration.

Enterprise data and analytics posture

Biotech and pharma

PEEL FOR CONTEXT.

Enterprise data and analytics posture

Biotech and pharma

Translate QML outputs into drug delivery, patient stratification, and operational decision support programs.

Workflow

From research signal to deployment conversation.

The operating model shows what the platform does, who it serves, and how secure collaboration fits into the flow.

05 step governed sequenceImaging to intervention laneProtected collaboration handoff
  1. 01

    Ingest complex imaging and related clinical inputs.

  2. 02

    Use QNN-driven analysis to sectionalize and characterize tumor regions.

  3. 03

    Generate secure treatment planning outputs and collaboration-ready insights.

  4. 04

    Support continued iteration with privacy and compliance language integrated throughout the stack.

  5. 05

    Publish milestone-ready operational summaries for partner review, delivery alignment, and secure execution planning.

Next step

Ready to get started?

Connect with NEXQ to discuss your oncology workflows, security posture, and deployment needs.